RxSight (RXST) Change in Inventory (2020 - 2026)
RxSight filings provide 6 years of Change in Inventory readings, the most recent being $3.2 million for Q4 2025.
- On a quarterly basis, Change in Inventory rose 690.44% to $3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.5 million, a 129.96% increase, with the full-year FY2025 number at $11.5 million, up 129.96% from a year prior.
- Change in Inventory hit $3.2 million in Q4 2025 for RxSight, down from $4.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $4.0 million in Q3 2022 to a low of -$1.4 million in Q4 2021.
- Median Change in Inventory over the past 5 years was $1.4 million (2021), compared with a mean of $1.4 million.
- Biggest five-year swings in Change in Inventory: surged 5282.14% in 2021 and later crashed 566.01% in 2023.
- RxSight's Change in Inventory stood at -$1.4 million in 2021, then soared by 85.5% to -$203000.0 in 2022, then crashed by 566.01% to -$1.4 million in 2023, then soared by 130.18% to $408000.0 in 2024, then soared by 690.44% to $3.2 million in 2025.
- The last three reported values for Change in Inventory were $3.2 million (Q4 2025), $4.0 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.